Similar companies
Income Statement (USD)
Q2 '24 | QoQ | |
---|---|---|
Revenue | 12.9B | 2% |
Gross Profit | 10.8B | 12.8% |
Cost of Revenue | 2.18B | 30.5% |
Operating expense | 10.2B | 62% |
Net Income | 1.93B | 11.6% |
Balance Sheet (USD)
Q2 '24 | QoQ | |
---|---|---|
Total Assets | 104B | 2% |
Total Liabilities | 64.7B | 0.1% |
Total Equity | 39.5B | 5.5% |
Shares Outstanding | 1.55B | 50.3% |
Cash Flow (USD)
Q2 '24 | QoQ | |
---|---|---|
Cash from operations | 3.09B | 19.6% |
EPS
Financial Highlights for Astrazeneca in Q2 '24
Astrazeneca reported a revenue of 12.9B, which is a 2% change from the previous quarter. An increase in revenue typically indicates growing demand for the company's products or services. This positive change in revenue is a good sign, suggesting that the company's sales are moving in the right direction.
Gross Profit stood at 10.8B, marking a 12.8% change since the last quarter. Gross profit showcases the efficiency in production and sales processes.
Cost of Revenue was 2.18B, a -30.5% difference from the previous quarter. A rising cost of revenue may suggest increased production or sales costs, which can impact margins. However, if accompanied by a proportionate rise in revenue, it could indicate scaling operations.
Operating Expenses for this period were 10.2B, showing a 62% change from the last quarter. Operating expenses cover the costs of running daily business operations. A significant increase might indicate inefficiencies or investments in growth, while a decrease could suggest cost-saving measures or potential underinvestment in key areas.
Net Income for the quarter was 1.93B, showing a -11.6% change from the prior quarter. Net income provides a clear picture of the company's profitability after all expenses. An increase suggests the company is becoming more profitable, while a decrease may raise concerns about the company's financial health, unless there are specific one-time costs or investments.
Astrazeneca faced some challenges this quarter with a decline in one or more of the key metrics: revenue, gross profit, or net income. Higher operating expenses might indicate increased investments or potential inefficiencies. A decline in EBITDA signals potential operational challenges or increased costs.